U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399080) titled 'Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease' on Sept. 30, 2025.
Brief Summary: The GENOSS PCB study aims to evaluate the safety and efficacy of a Paclitaxel-coated PTA Balloon Catheter(GENOSS(R) PCB) in patients with the femoropopliteal artery disease.
Study Start Date: July 01, 2025
Study Type: OBSERVATIONAL
Condition:
PTA (Percutaneous Transluminal Angioplasty )
Femoropopliteal Artery Disease
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Genoss Co., Ltd.
Disclaimer: Curated by HT Syndication....